Grey Matters Health Inc

OTC • Healthcare • Biotechnology • Quote as of 10/30/2026

Company Profile

IndustryBiotechnology

SectorHealthcare

ExchangeOTC

Market Capitalization2.31 mln

Float6.75 mln

Earnings Date10/29/2026

Piotroski F-Score

3 / 9

Below average

Relative Strength

16 / 100

Significantly lagging

Debt / Equity

0.44

Low leverage

ROE

-97.90

Deeply negative

ROA

-43.73

Deeply negative

Business Description

Algernon Health Inc. is a Canadian company that develops new medicines to treat serious conditions such as kidney disease, liver disease, and stroke. Founded in 2015 and based in Vancouver, the company also conducts research in Australia. Its current drug candidates include repirinast, aimed at chronic kidney disease, and DMT, being studied as a potential treatment for stroke and traumatic brain injury.

Key Fundamentals

EPS-0.36

ROE-97.90

ROIC-42.22

ROA-43.73

EBITDA, mln-1.46

EV / EBITDA-2.10

EV / EBIT-1.95

Quote Details

Last 0.2403

Change -0.0255 (-9.6%)

Open 0.2403

Volume 124

Turnover 29.79

Average Volume 9,059.62

Financial Ratios

Current Ratio0.13

Price / Book1.65

Debt / Equity0.44

Financial Strength

Piotroski F-Score 3 / 9

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-4.74%	28 / 100
1 Month	-40.38%	6 / 100
2 Months	-34%	17 / 100
6 Months	-59.96%	10 / 100
1 Year	-61.74%	13 / 100